{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:03:16Z","timestamp":1771362196666,"version":"3.50.1"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,1,19]]},"DOI":"10.18632\/oncotarget.6505","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T04:57:29Z","timestamp":1449637049000},"page":"3461-3476","source":"Crossref","is-referenced-by-count":8,"title":["Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Aloke","family":"Sarkar","sequence":"first","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumudha","family":"Balakrishnan","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Department of Leukemia, UT MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jefferson","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viralkumar","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"McMurray","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Department of Leukemia, UT MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Campo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/pmic.200800080","article-title":"Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study","volume":"8","author":"Chilosi","year":"2008","journal-title":"Proteomics"},{"key":"3","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dolcetti","year":"2008","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Zago","year":"2005","journal-title":"Br J Haematol"},{"key":"5","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Campo","year":"2012","journal-title":"J Clin Invest"},{"key":"6","first-page":"a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"Mak","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20041142","article-title":"The protein structures that shape caspase activity, specificity, activation and inhibition","volume":"384","author":"Salvesen","year":"2004","journal-title":"Biochem J"},{"key":"8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Liu","year":"2004","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1073\/pnas.0507493103","article-title":"Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy","volume":"103","author":"Vassilev","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Li","year":"2005","journal-title":"Nature"},{"key":"11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CAD.0b013e32832ced78","article-title":"Smac mimetics as new cancer therapeutics","volume":"20","author":"Huerta","year":"2009","journal-title":"Anticancer Drugs"},{"key":"12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","article-title":"Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy","volume":"2","author":"Hergenrother","year":"2006","journal-title":"Nat Chem Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lymphoma by protein microarray","volume":"105","author":"Witzig","year":"2005","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jmb.2009.03.003","article-title":"PAC-1 activates procaspase-3through relief of zinc-mediated inhibition","volume":"388","author":"Hergenrother","year":"2009","journal-title":"J Mol Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/0008-5472.CAN-10-0766","article-title":"Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound","volume":"70","author":"Fan","year":"2010","journal-title":"Cancer research"},{"key":"16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/co2001372","article-title":"Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1)","volume":"14","author":"Hergenrother","year":"2012","journal-title":"ACS Comb Sci"},{"key":"17","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2006-03-007468","article-title":"Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1096\/fj.10-173757","article-title":"Serum response factor expression is enriched in pancreatic beta cells and regulates insulin gene expression","volume":"25","author":"Belaguli","year":"2011","journal-title":"FASEB J"},{"key":"19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Lai","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"18530","DOI":"10.1074\/jbc.272.30.18530","article-title":"Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis","volume":"272","author":"Hannun","year":"1997","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"25719","DOI":"10.1074\/jbc.272.41.25719","article-title":"Biochemical characteristics of caspases-3, -6, -7, and -8","volume":"272","author":"Salvesen","year":"1997","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/pro.2090","article-title":"Mechanism of zinc-mediated inhibition of caspase-9","volume":"21","author":"Hardy","year":"2012","journal-title":"Protein Sci"},{"key":"23","doi-asserted-by":"crossref","first-page":"36000","DOI":"10.1074\/jbc.M112.397752","article-title":"Zinc-mediated allosteric inhibition of caspase-6","volume":"287","author":"Hardy","year":"2012","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nsb0796-619","article-title":"The three-dimensional structure of apopain\/CPP32, a key mediator of apoptosis","volume":"3","author":"Becker","year":"1996","journal-title":"Nat Struct Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(01)00274-4","article-title":"Structural basis for the inhibition of caspase-3 by XIAP","volume":"104","author":"Salvesen","year":"2001","journal-title":"Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1021\/bi0611964","article-title":"Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3","volume":"45","author":"Clark","year":"2006","journal-title":"Biochemistry"},{"key":"27","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","article-title":"Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways","volume":"23","author":"Rosenwald","year":"2005","journal-title":"J Clin Oncol"},{"key":"28","first-page":"1","article-title":"Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network","author":"Zaja","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"29","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Marra","year":"2012","journal-title":"Blood"},{"key":"30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.beha.2012.04.005","article-title":"The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL)","volume":"25","author":"Hernandez-Ilizaliturri","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2010.09.003","article-title":"Mantle cell lymphoma: the promise of new treatment options","volume":"80","author":"Kahl","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Wiestner","year":"2011","journal-title":"Blood"},{"key":"33","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Reed","year":"2008","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Lowe","year":"2001","journal-title":"Nature"},{"key":"35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ceb.2003.10.004","article-title":"Bcl-2-family proteins and the role of mitochondria in apoptosis","volume":"15","author":"Newmeyer","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1073\/pnas.0610877104","article-title":"Targeted cell killing by reconstituted caspases","volume":"104","author":"Chalfie","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nchembio.318","article-title":"Turning enzymes ON with small molecules","volume":"6","author":"Wells","year":"2010","journal-title":"Nat Chem Biol"},{"key":"38","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1021\/ja4124303","article-title":"Dual small-molecule targeting of procaspase-3 dramatically enhances zymogen activation and anticancer activity","volume":"136","author":"Hergenrother","year":"2014","journal-title":"Journal of the American Chemical Society"},{"key":"39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood-2014-01-546796","article-title":"Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells","volume":"125","author":"Gandhi","year":"2015","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4402059","article-title":"Caspase substrates","volume":"14","author":"Salvesen","year":"2007","journal-title":"Cell Death Differ"},{"key":"41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Shi","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"42","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1021\/bi034998x","article-title":"An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3","volume":"42","author":"Clark","year":"2003","journal-title":"Biochemistry"},{"key":"43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.exphem.2015.07.005","article-title":"Targeting executioner procaspase-3 with the procaspase activating compound B-PAC-1 induces apoptosis in multiple myeloma cells","volume":"43","author":"Gandhi","year":"2015","journal-title":"Exp Hematol"},{"key":"44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/path.1711230404","article-title":"Apoptosis in the small intestine of zinc-deficient and fasted rats","volume":"123","author":"Elmes","year":"1977","journal-title":"J Pathol"},{"key":"45","first-page":"338","article-title":"Programmed cell death (apoptosis) in lymphoid and myeloid cell lines during zinc deficiency","volume":"83","author":"Hannigan","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"46","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1073\/pnas.80.20.6361","article-title":"Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis","volume":"80","author":"Cohen","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10534-010-9302-8","article-title":"Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes","volume":"23","author":"Cervinka","year":"2010","journal-title":"Biometals"},{"key":"48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1440-1711.1999.00825.x","article-title":"Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review","volume":"77","author":"Zalewski","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"49","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0006-2952(03)00498-2","article-title":"Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation","volume":"66","author":"Zalewski","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(94)90303-4","article-title":"Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20\/p10)2 homodimer","volume":"78","author":"Hammill","year":"1994","journal-title":"Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T16:36:53Z","timestamp":1653755813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,1,19]]}},"alternative-id":["6505","26658105"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6505","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}